Covid Part 2?

This entry was posted in CDC, COVID, Gaslighting, W.H.O.. Bookmark the permalink.

4 Responses to Covid Part 2?

  1. czarina33's avatar czarina33 says:

    COVID hysteria, replaced by Climate crisis, Russia/China war, microplastics insanity. Just recycle around to match whatever the politicians & media want us to believe at any particular time.

    Like

  2. Reflection's avatar Reflection says:

    Distraction, diversion and division while they are demonstratively stealing, killing and destroying.

    12 For it is a shame even to speak of those things which are done of them in secret.

    13 But all things that are reproved are made manifest by the light: for whatsoever doth make manifest is light.
    Ephesians 5:12-13, KJV

    A salute to all the stellar light bearers.

    Liked by 2 people

  3. Reflection's avatar Reflection says:

    Czarina,

    One caveat: There may one day be a real deadly outbreak because of attempts to create ever more potent viruses and other pathogens.

    Ever vigilant seems to be the new status quo.

    Liked by 1 person

  4. Reflection's avatar Reflection says:

    Here are the links to the salient facts:

    One death globally.

    https://humanevents.com/2024/06/07/mexican-health-secretary-denies-citizen-died-of-bird-flu

    https://legalinsurrection.com/2024/06/human-bird-flu-death-in-mexico-turns-out-to-be-fakenews/

    https://www.dossier.today/p/deborah-birx-proposes-weekly-testing

    Since leaving government work, Birx has already earned millions of dollars in the private sector, and has found herself quite a few lucrative opportunitites in the Pharma space.

    Birx now sits on the advisory board of BGR, one of the most powerful lobbying firms in Washington D.C. Their Pharma client roster includes the likes of Pfizer, Abbott Labs, GSK, and Johnson & Johnson, to name a few.

    Birx is also the CEO of a publicly traded company called Armata Pharmaceuticals, through which she was granted about 275,000 shares. As of Wednesday, her holdings in Armata are valued at about $728,750. Birx also earns a base salary of $525,000 per year, and she can earn a massive performance bonus based on the value of the company.

    Armata is 70% owned by another publicly traded company called Innoviva, which describes itself as a “Healthcare Royalty and Asset Management” company. Innoviva’s top shareholders include BlackRock and Vanguard, which, through their clients’ positions, control about 25% of Innoviva.

    Birx also holds several additional board seats in startup and seasoned Pharma endeavors, some of which may stand to acquire significant government funding in the event of a manufactured pandemic scenario.

    Like

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.